The use of glucagon-like peptide-1 agonists as a treatment for obesity in older people: risks and benefits.
PURPOSE OF REVIEW Obesity is an increasingly important health problem in older adults (≥65 years) and is associated with osteoarthritis, impaired mobility, reduced quality of life, cardiovascular disease, and other age-related comorbidities. This narrative review summarizes the current evidence regarding the benefits a...